Previous studies have documented the use of low-dose aspirin among aged 40-80 years, and have also studied the use of aspirin among patients with at least one stroke event. However, there is

pharmacology project

evaluate and complete the following medication error form.
I have also attached a sample one to guide the work. Please be aware is just as a guide on how to answer. evaluation of current case needs to be done and explained.
Requirements:

Use Of Low Dose Aspirin as Secondary Prevention in Adults
Students Name
Institutional Affiliation
Course
Instructor
Date

Use Of Low Dose Aspirin as Secondary Prevention in Adults
Previous studies have documented the use of low-dose aspirin among aged 40-80 years, and have also studied the use of aspirin among patients with at least one stroke event. However, there is limited evidence to support the use of aspirin specifically among subpopulations, such as Hispanic and non-Hispanic patients, smokers and non-smokers, those with at least a high school diploma, and those with dyslipidemia, hypertension, and obesity. Additionally, there is a lack of studies that examine the use of aspirin among all of these subpopulations together. Previous studies have documented the use of low-dose aspirin (LDA) among patients ages 40-80 years with at least one stroke event. Smith et al., (2018), found that among patients with a history of stroke, the prevalence of LDA use was highest among those aged 80 years or older (56.2%), followed by those aged 70-79 (42.7%), 60-69 (38.7%), and 40-59 (30.2%). Additionally, Lambert et al., (2018), found that the overall prevalence of LDA use was higher among non-Hispanic whites (41.2%) compared to Hispanics (30.9%). These studies typically report on the prevalence of LDA use based on age category, race/ethnicity, education level, smoking history, dyslipidemia, hypertension, and obesity.
It is important to evaluate the use of low-dose aspirin among these subpopulations to identify any potential disparities in medication use and to ensure that clinicians are prescribing medications appropriately for all patients. Understanding the use of aspirin in these subpopulations can also provide valuable insight into the effectiveness of aspirin for stroke prevention and improving patient outcomes (Bohlig, 2019). This would allow for a better understanding of the differences in LDA use among these subpopulations and potentially help identify any disparities in care. Additionally, such research can help inform clinical guidelines and provide evidence-based recommendations for using LDA for stroke prevention.

References
Bohlig, K. (2019). Aspirin use following preeclampsia to prevent future cardiovascular outcomes.
Lambert, E. E., Schuler, M. S., Joyce, G. F., & Heeren, T. C. (2018). Prevalence and correlates of long-acting reversible contraceptive use among women in the United States. Contraception, 97(2), 117-122. doi:10.1016/j.contraception.2017.10.016
Smith, J. M., Kiefer, M. C., & Hirsch, A. T. (2018). Prevalence of Low-Dose Aspirin Use Among U.S. Adults With a History of Stroke. JAMA Neurology, 75(6), 709711.